FDA sued for failing to act on painkiller

A consumer group has sued the FDA, saying the agency has been too slow in acting against the painkiller known as Darvon, a.k.a. propoxyphene. In its suit, Public Citizen says FDA broke the law by not ruling on its petition against drug, which it filed two years ago. The agency was required to act on it within six months, the suit says. Report

Suggested Articles

With a brand new approval for Adakveo under its belt, Novartis Sunday flaunted an analysis showing the drug could cut patient hospitalizations by 40%.

BeiGene only just won its first Brukinsa nod in MCL. But it’s already pushing to join the CLL field, and Sunday it rolled out more data.

How long can one infusion of CAR-T drug Yescarta continue helping patients with refractory large B-cell lymphoma? Pretty long, Gilead showed Saturday.